Abdulkader Puranwala

Hi. And thank you for the opportunity. So, first is a follow -up on, you know, the CGHS question. So, with the reimbursements now other hospitals are also talking about, you know, that not being profitable. Have you guys along with, you know, other hospitals started to approach the Government and the CGHS guys to roll this back to the previous levels?

Understood. Got it. And, you know, there were certain media articles highlighting that the insurance companies have been now trying to dictate the terms at which patients, you know, get admitted and the kind of care should be offered.

Got it. And so, between say just on a bookkeeping question, between quarter one of this year versus last year, would it be fair to assume that, you know, the overheads of the new hospitals along with the onco drugs getting discontinued may have say up to INR 100 crore to INR 150 crore kind of an impact on your EBITDA?